Clinical trial NCT02758288 - References

BK Virus Infection — BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach

Citation(s)

•   Aldred KJ, Kerns RJ, Osheroff N
  Mechanism of quinolone action and resistance. Biochemistry. 2014 Mar 18;53(10):1565-74. doi: 10.1021/bi5000564. Epub 2014 Mar 7. Review.
•   Alghamdi S, Nabi Z, Skolnik E, Alkorbi L, Albaqumi M
  Cyclosporine versus tacrolimus maintenance therapy in renal transplant. Exp Clin Transplant. 2011 Jun;9(3):170-4.
•   Araya CE, Garin EH, Neiberger RE, Dharnidharka VR
  Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients. Pediatr Transplant. 2010 Feb;14(1):145-50. doi: 10.1111/j.1399-3046.2009.01183.x. Epub 2009 Mar 31.
•   Balba GP, Javaid B, Timpone JG Jr
  BK polyomavirus infection in the renal transplant recipient. Infect Dis Clin North Am. 2013 Jun;27(2):271-83. doi: 10.1016/j.idc.2013.02.002. Epub 2013 Apr 17. Review.
•   Binet I, Nickeleit V, Hirsch HH, Prince O, Dalquen P, Gudat F, Mihatsch MJ, Thiel G
  Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999 Mar 27;67(6):918-22.
•   Boothpur R, Brennan DC
  Human polyoma viruses and disease with emphasis on clinical BK and JC. J Clin Virol. 2010 Apr;47(4):306-12. doi: 10.1016/j.jcv.2009.12.006. Epub 2010 Jan 8. Review.
•   Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, Torrence S, Schuessler R, Roby T, Gaudreault-Keener M, Storch GA
  Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005 Mar;5(3):582-94. Erratum in: Am J Transplant. 2005 Apr;5(4 Pt 1):839.
•   Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM
  A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant. 2005 Aug;5(8):1926-33.
•   Cekmen MB, Bakirdoven S, Sayan M, Yilmaz A
  BK virus nephropathy developing after renal transplantation and its treatment with ciprofloxacin: a case report. Transplant Proc. 2012 Dec;44(10):3044-7. doi: 10.1016/j.transproceed.2012.03.059.
•   Chalasani G, Li Q, Konieczny BT, Smith-Diggs L, Wrobel B, Dai Z, Perkins DL, Baddoura FK, Lakkis FG
  The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J Immunol. 2004 Jun 15;172(12):7813-20.
•   Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC
  Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol. 2005 Dec;36(12):1245-55. Epub 2005 Oct 19. Review.
•   Duan KI, Englesbe MJ, Volk ML
  Centers for Disease Control 'high-risk' donors and kidney utilization. Am J Transplant. 2010 Feb;10(2):416-20. doi: 10.1111/j.1600-6143.2009.02931.x. Epub 2009 Dec 2.
•   Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ
  The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004 Nov 19;306(5700):1380-3.
•   Gardner SD, Field AM, Coleman DV, Hulme B
  New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971 Jun 19;1(7712):1253-7.
•   Ginevri F, Azzi A, Hirsch HH, Basso S, Fontana I, Cioni M, Bodaghi S, Salotti V, Rinieri A, Botti G, Perfumo F, Locatelli F, Comoli P
  Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant. 2007 Dec;7(12):2727-35. Epub 2007 Oct 1.
•   Han SB, Cho B, Kang JH
  BK virus-associated hemorrhagic cystitis after pediatric stem cell transplantation. Korean J Pediatr. 2014 Dec;57(12):514-9. doi: 10.3345/kjp.2014.57.12.514. Epub 2014 Dec 31. Review.
•   Hariharan S
  BK virus nephritis after renal transplantation. Kidney Int. 2006 Feb;69(4):655-62. Review.
•   Hirsch HH, Randhawa P; AST Infectious Diseases Community of Practice
  BK virus in solid organ transplant recipients. Am J Transplant. 2009 Dec;9 Suppl 4:S136-46. doi: 10.1111/j.1600-6143.2009.02904.x.
•   Hirsch HH, Steiger J
  Polyomavirus BK. Lancet Infect Dis. 2003 Oct;3(10):611-23. Review.
•   Hirsch HH, Vincenti F, Friman S, Tuncer M, Citterio F, Wiecek A, Scheuermann EH, Klinger M, Russ G, Pescovitz MD, Prestele H
  Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant. 2013 Jan;13(1):136-45. doi: 10.1111/j.1600-6143.2012.04320.x. Epub 2012 Nov 8.
•   Hoppe-Seyler K, Sauer P, Lohrey C, Hoppe-Seyler F
  The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro. Hepatology. 2012 Jul;56(1):9-16. doi: 10.1002/hep.25602. Epub 2012 Jun 1.
•   Huang G, Chen LZ, Qiu J, Wang CX, Fei JG, Deng SX, Li J, Chen GD, Zhang L, Fu Q, Zeng WT, Zhao DQ
  Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China: a single-center analysis of incidence, reduction in immunosuppression and clinical course. Clin Transplant. 2010 Sep-Oct;24(5):599-609. doi: 10.1111/j.1399-0012.2009.01141.x.
•   Israni AK, Salkowski N, Gustafson S, Snyder JJ, Friedewald JJ, Formica RN, Wang X, Shteyn E, Cherikh W, Stewart D, Samana CJ, Chung A, Hart A, Kasiske BL
  New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. J Am Soc Nephrol. 2014 Aug;25(8):1842-8. doi: 10.1681/ASN.2013070784. Epub 2014 May 15.
•   Johnston TD, Thacker LR, Jeon H, Lucas BA, Ranjan D
  Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant. 2004;18 Suppl 12:28-32.
•   Kadambi PV, Josephson MA, Williams J, Corey L, Jerome KR, Meehan SM, Limaye AP
  Treatment of refractory BK virus-associated nephropathy with cidofovir. Am J Transplant. 2003 Feb;3(2):186-91.
•   Kahan AV, Coleman DV, Koss LG
  Activation of human polyomavirus infection-detection by cytologic technics. Am J Clin Pathol. 1980 Sep;74(3):326-32.
•   Knoll GA, Bell RC
  Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ. 1999 Apr 24;318(7191):1104-7.
•   Leung AY, Chan MT, Yuen KY, Cheng VC, Chan KH, Wong CL, Liang R, Lie AK, Kwong YL
  Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005 Feb 15;40(4):528-37. Epub 2005 Jan 21.
•   Mateo R, Cho Y, Singh G, Stapfer M, Donovan J, Kahn J, Fong TL, Sher L, Jabbour N, Aswad S, Selby RR, Genyk Y
  Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant. 2006 Apr;6(4):791-6.
•   Matsuoka L, Shah T, Aswad S, Bunnapradist S, Cho Y, Mendez RG, Mendez R, Selby R
  Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor kidney transplantation. Am J Transplant. 2006 Jun;6(6):1473-8.
•   Monaco MC, Jensen PN, Hou J, Durham LC, Major EO
  Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol. 1998 Dec;72(12):9918-23.
•   Moscarelli L, Caroti L, Antognoli G, Zanazzi M, Di Maria L, Carta P, Minetti E
  Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience. Clin Transplant. 2013 Jul-Aug;27(4):546-54. doi: 10.1111/ctr.12151. Epub 2013 Jun 13.
•   Nickeleit V, Hirsch HH, Zeiler M, Gudat F, Prince O, Thiel G, Mihatsch MJ
  BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant. 2000 Mar;15(3):324-32. Review.
•   Nickeleit V, Klimkait T, Binet IF, Dalquen P, Del Zenero V, Thiel G, Mihatsch MJ, Hirsch HH
  Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med. 2000 May 4;342(18):1309-15.
•   Padgett BL, Walker DL
  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973 Apr;127(4):467-70.
•   Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K
  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993 Sep 15;270(11):1339-43.
•   Ramos E, Drachenberg CB, Papadimitriou JC, Hamze O, Fink JC, Klassen DK, Drachenberg RC, Wiland A, Wali R, Cangro CB, Schweitzer E, Bartlett ST, Weir MR
  Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002 Aug;13(8):2145-51.
•   Randhawa P, Ho A, Shapiro R, Vats A, Swalsky P, Finkelstein S, Uhrmacher J, Weck K
  Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol. 2004 Mar;42(3):1176-80.
•   Randhawa PS
  Anti-BK virus activity of ciprofloxacin and related antibiotics. Clin Infect Dis. 2005 Nov 1;41(9):1366-7; author reply 1367.
•   Renner FC, Dietrich H, Bulut N, Celik D, Freitag E, Gaertner N, Karoui S, Mark J, Raatz C, Weimer R, Feustel A
  The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects. Transplant Proc. 2013 May;45(4):1608-10. doi: 10.1016/j.transproceed.2013.01.026.
•   Rinaldo CH, Tylden GD, Sharma BN
  The human polyomavirus BK (BKPyV): virological background and clinical implications. APMIS. 2013 Aug;121(8):728-45. doi: 10.1111/apm.12134. Epub 2013 Jun 19. Review.
•   Ronco C
  Biomarkers for acute kidney injury: is NGAL ready for clinical use? Crit Care. 2014 Dec 10;18(6):680. doi: 10.1186/s13054-014-0680-0.
•   Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ
  Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998 Nov;9(11):2135-41.
•   Tonelli M, Wiebe N, Knoll G, Bello A, Browne S, Jadhav D, Klarenbach S, Gill J
  Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011 Oct;11(10):2093-109. doi: 10.1111/j.1600-6143.2011.03686.x. Epub 2011 Aug 30.
•   Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP
  BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int. 2005 Oct;68(4):1834-9.
•   Williams JW, Javaid B, Kadambi PV, Gillen D, Harland R, Thistlewaite JR, Garfinkel M, Foster P, Atwood W, Millis JM, Meehan SM, Josephson MA
  Leflunomide for polyomavirus type BK nephropathy. N Engl J Med. 2005 Mar 17;352(11):1157-8.
•   Zaman RA, Ettenger RB, Cheam H, Malekzadeh MH, Tsai EW
  A novel treatment regimen for BK viremia. Transplantation. 2014 Jun 15;97(11):1166-71. doi: 10.1097/01.TP.0000441825.72639.4f.

BK Viremia and BK Virus Nephropathy Post Kidney Transplant Comparison of New Practices With Traditional Approach: A Combined Retrospective Chart Review and Prospective Observational Study

Details for clinical trial NCT02758288